BioCentury | May 5, 2014
Company News

Caprion Proteomics sales and marketing update

...142 proteins in 75 µL of human CSF in a single, multiplexed multiple reaction monitoring (MRM...
BioCentury | Oct 21, 2013
Company News

MRM, Jain Foundation, The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) deal

...The not-for-profit PROOF Centre and MRM Proteomics partnered with the Jain Foundation to identify blood-based biomarkers...
...muscular dystrophy 2B or Miyoshi myopathy. Jain said it is the sole funder and that MRM...
...Jain said it will identify patients through its patient registry and participate throughout the collaboration, MRM...
BioCentury | Oct 21, 2013
Financial News

Sofie completes venture financing

...Diagnostic Date completed: 10/15/13 Type: Venture financing Raised: $5 million Investors: Tata Industries; Cycad Group; MRM...
BioCentury | Jun 18, 2012
Company News

NextGen sales and marketing update

...of diagnostics for CNS diseases. CSFassay-rat A.1.0 is based on the company's multiple reaction monitoring (MRM...
BioCentury | Jun 27, 2011
Company News

NextGen sales and marketing update

...and amyotrophic lateral sclerosis (ALS). The assay is based on the company's multiple reaction monitoring (MRM...
BioCentury | Apr 18, 2011
Company News

NextGen sales and marketing update

...of breast cancer. The multiplex protein assay is based on the company's multiple reaction monitoring (MRM...
BioCentury | Oct 4, 2010
Emerging Company Profile

Integrated Diagnostics: Multiplexed detection

...Diagnostics solves this problem by using a mass spectroscopy technology known as multiple reaction monitoring (MRM...
...sample preparation, instrumentation and software that have increased the sensitivity and high throughput capabilities of MRM-based...
...to diagnose Alzheimer's disease (AD), and has licensed 500 putative markers. The company is building MRM...
BioCentury | Feb 8, 2010
Company News

NextGen, Takeda deal

...NextGen's NextGen Sciences subsidiary will use its Multiple Reaction Monitoring (MRM) protein assay technology to develop...
BioCentury | Oct 8, 2007
Regulation

Significant isn't meaningful

...indicated for the acute treatment of MRM. The first Phase III trial of frovatriptan for MRM...
...groups vs. placebo. Secondary endpoints included the severity and duration of MRM headache, incidence of MRM-associated...
...the same as in the first trial. The primary endpoint was number of MRM-free PMPs. MRM...
BioCentury | Oct 8, 2007
Regulation

Frova efficacy

...MRM) headache during the treated perimenstrual period (PMP) in the first trial and number of MRM-free...
...mg Frova daily (n=483) % of patients with: MRM 67% 52% (p<0.0001) 41% (p<0.0001) Moderate/severe MRM...
...p<0.0001) % of patients with severe MRM 58% 44% (p=0.007) 40% (p=0.0003) Ratio of severe-to-mild MRM...
Items per page:
1 - 10 of 16
BioCentury | May 5, 2014
Company News

Caprion Proteomics sales and marketing update

...142 proteins in 75 µL of human CSF in a single, multiplexed multiple reaction monitoring (MRM...
BioCentury | Oct 21, 2013
Company News

MRM, Jain Foundation, The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) deal

...The not-for-profit PROOF Centre and MRM Proteomics partnered with the Jain Foundation to identify blood-based biomarkers...
...muscular dystrophy 2B or Miyoshi myopathy. Jain said it is the sole funder and that MRM...
...Jain said it will identify patients through its patient registry and participate throughout the collaboration, MRM...
BioCentury | Oct 21, 2013
Financial News

Sofie completes venture financing

...Diagnostic Date completed: 10/15/13 Type: Venture financing Raised: $5 million Investors: Tata Industries; Cycad Group; MRM...
BioCentury | Jun 18, 2012
Company News

NextGen sales and marketing update

...of diagnostics for CNS diseases. CSFassay-rat A.1.0 is based on the company's multiple reaction monitoring (MRM...
BioCentury | Jun 27, 2011
Company News

NextGen sales and marketing update

...and amyotrophic lateral sclerosis (ALS). The assay is based on the company's multiple reaction monitoring (MRM...
BioCentury | Apr 18, 2011
Company News

NextGen sales and marketing update

...of breast cancer. The multiplex protein assay is based on the company's multiple reaction monitoring (MRM...
BioCentury | Oct 4, 2010
Emerging Company Profile

Integrated Diagnostics: Multiplexed detection

...Diagnostics solves this problem by using a mass spectroscopy technology known as multiple reaction monitoring (MRM...
...sample preparation, instrumentation and software that have increased the sensitivity and high throughput capabilities of MRM-based...
...to diagnose Alzheimer's disease (AD), and has licensed 500 putative markers. The company is building MRM...
BioCentury | Feb 8, 2010
Company News

NextGen, Takeda deal

...NextGen's NextGen Sciences subsidiary will use its Multiple Reaction Monitoring (MRM) protein assay technology to develop...
BioCentury | Oct 8, 2007
Regulation

Significant isn't meaningful

...indicated for the acute treatment of MRM. The first Phase III trial of frovatriptan for MRM...
...groups vs. placebo. Secondary endpoints included the severity and duration of MRM headache, incidence of MRM-associated...
...the same as in the first trial. The primary endpoint was number of MRM-free PMPs. MRM...
BioCentury | Oct 8, 2007
Regulation

Frova efficacy

...MRM) headache during the treated perimenstrual period (PMP) in the first trial and number of MRM-free...
...mg Frova daily (n=483) % of patients with: MRM 67% 52% (p<0.0001) 41% (p<0.0001) Moderate/severe MRM...
...p<0.0001) % of patients with severe MRM 58% 44% (p=0.007) 40% (p=0.0003) Ratio of severe-to-mild MRM...
Items per page:
1 - 10 of 16